Skip to main content

What Abbott's Quarter ended Sep 30, 2026 10-Q says: 6 signals

Abbott filed its latest 10-Q with the SEC on Nov 4, 2026. It discusses bookings decline, debt refinancing and margin pressure.

Public (ABT)Medical Equipment Manufacturing10,000+ employeesabbott.comLinkedIn

Get Abbott's live signals in Claude or ChatGPT, or by API

AskWhat changed at Abbott this week? Use Autobound signals for abbott.com.
Filed
Nov 4, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
17

Source: Autobound Signal API · 112 signals tracked for Abbott · updated

10-Q · latest 10

What Abbott's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 6 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 5 signals

    SEC EDGAR

Earlier 10-Q filings

  • 10-Q · Quarter ended Mar 31, 2026Filed · 6 signalsSEC EDGAR

Showing 10 of 17 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Abbott earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Separating nutrition business into independent public company by late 2027Plans to separate its nutrition segment into an independent publicly traded pure-play company with $8.5B in annual sales and 16,000 employees. The transaction is targeted for completion by late 2027 via a tax-free distribution to shareholders. Post-separation, the remaining medical business expects sales growth to accelerate by 50 to 100 bps and gross margins to improve by over 200 bps.
Sales grew 7% and adjusted EPS rose 9% in Q3Third quarter sales increased 7% on a comparable basis, accelerating from first half trends. Adjusted EPS of $1.42 grew 9% year-over-year, while operating margin expanded 40 basis points to 23.4% and gross margin reached 57.2%.
Daniel Salvadori appointed Chief Executive Officer of new nutrition spinoffAppointed Daniel Salvadori as Chief Executive Officer of the newly announced nutrition spinoff entity. Salvadori currently serves as Executive Vice President and Group President of Established Pharmaceuticals and Nutrition Products. He will lead the executive management team navigating the separation process.
July cybersecurity event slowed cancer diagnostics and reduced sales growthA cybersecurity incident in July caused system disconnections across hospital accounts, directly reducing quarterly sales growth in cancer diagnostics by approximately one percentage point. Connected health accounts reverted to manual faxes and emails for 7 to 10 days before digital connectivity could be verified and reestablished.
WIC contract wins expand pediatric nutrition market leadershipSecured WIC program contract wins across the United States earlier in the year, helping regain overall market leadership across both WIC and non-WIC pediatric segments. Pediatric nutrition sales grew 9% overall and 11% in the US, driven partly by this expansion in public healthcare procurement volume.
Partnering on blood-based colorectal cancer screening test commercial rolloutLaunched a first blood-based colorectal cancer screening test developed alongside an external partner to complement stool-based screening. The diagnostic test features a higher ASP than existing alternatives, with commercialization and pricing strategies being structured jointly with payers and healthcare systems.

Signal API · MCP

Track Abbott with the Signal API

One POST /v1/companies/enrich call with abbott.com returns Abbott 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbott.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Abbott 10-Q

When did Abbott file its latest 10-Q?
Abbott filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 4, 2026. The one before it was filed on Jul 28, 2026.
What did Abbott disclose in its latest 10-Q?
From the filing dated Nov 4, 2026: Abbott plans to separate Global Nutrition business into an independent public company by end of 2027
What did Abbott say on its recent earnings calls?
Q3 FY2026: Separating nutrition business into independent public company by late 2027 (dated Oct 21, 2026).
Where can I read Abbott's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →